HK1042483B - 四氫噻唑的製造方法 - Google Patents
四氫噻唑的製造方法 Download PDFInfo
- Publication number
- HK1042483B HK1042483B HK02103306.1A HK02103306A HK1042483B HK 1042483 B HK1042483 B HK 1042483B HK 02103306 A HK02103306 A HK 02103306A HK 1042483 B HK1042483 B HK 1042483B
- Authority
- HK
- Hong Kong
- Prior art keywords
- salts
- thiazolidin
- formula
- production
- reaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19926233.0 | 1999-06-10 | ||
| DE19926233A DE19926233C1 (de) | 1999-06-10 | 1999-06-10 | Verfahren zur Herstellung von Thiazolidin |
| PCT/EP2000/003213 WO2000076986A1 (de) | 1999-06-10 | 2000-04-11 | Verfahren zur herstellung von thiazolidin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1042483A1 HK1042483A1 (zh) | 2002-08-16 |
| HK1042483B true HK1042483B (zh) | 2004-09-10 |
Family
ID=7910641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK02103306.1A HK1042483B (zh) | 1999-06-10 | 2000-04-11 | 四氫噻唑的製造方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6559314B2 (zh) |
| EP (1) | EP1185520B1 (zh) |
| JP (1) | JP3803292B2 (zh) |
| KR (1) | KR100467898B1 (zh) |
| CN (1) | CN1169799C (zh) |
| AT (1) | ATE261946T1 (zh) |
| AU (1) | AU758605B2 (zh) |
| BR (1) | BR0011445A (zh) |
| CA (1) | CA2373834C (zh) |
| DE (2) | DE19926233C1 (zh) |
| DK (1) | DK1185520T3 (zh) |
| ES (1) | ES2215045T3 (zh) |
| HK (1) | HK1042483B (zh) |
| MX (1) | MXPA01012237A (zh) |
| NZ (1) | NZ515561A (zh) |
| PT (1) | PT1185520E (zh) |
| RU (1) | RU2218336C2 (zh) |
| WO (1) | WO2000076986A1 (zh) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2304206A1 (en) * | 1997-09-29 | 1999-04-08 | Point Therapeutics, Inc. | Stimulation of hematopoietic cells in vitro |
| US6979697B1 (en) * | 1998-08-21 | 2005-12-27 | Point Therapeutics, Inc. | Regulation of substrate activity |
| US6890904B1 (en) * | 1999-05-25 | 2005-05-10 | Point Therapeutics, Inc. | Anti-tumor agents |
| US7550590B2 (en) | 2003-03-25 | 2009-06-23 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| EP1625122A1 (en) | 2003-05-14 | 2006-02-15 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| ZA200602051B (en) | 2003-08-13 | 2007-10-31 | Takeda Pharmaceutical | 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| EP1699777B1 (en) | 2003-09-08 | 2012-12-12 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| BRPI0418639B8 (pt) | 2004-03-15 | 2021-05-25 | Takeda Pharmaceutical | compostos inibidores de dipeptidil peptidase, assim como composição farmacêutica contendo os mesmos |
| US7687638B2 (en) * | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| WO2006019965A2 (en) | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| CN101087756B (zh) * | 2004-07-23 | 2011-04-06 | 纽阿达有限责任公司 | 肽酶抑制剂 |
| US20060063719A1 (en) * | 2004-09-21 | 2006-03-23 | Point Therapeutics, Inc. | Methods for treating diabetes |
| WO2006068978A2 (en) | 2004-12-21 | 2006-06-29 | Takeda Pharmaceutial Company Limited | Dipeptidyl peptidase inhibitors |
| US20070060529A1 (en) * | 2005-09-14 | 2007-03-15 | Christopher Ronald J | Administration of dipeptidyl peptidase inhibitors |
| HRP20140091T4 (hr) * | 2005-09-14 | 2021-12-24 | Takeda Pharmaceutical Company Limited | Davanje inhibitora dipeptidil peptidaze |
| ZA200802857B (en) | 2005-09-14 | 2009-09-30 | Takeda Pharmaceutical | Dipeptidyl peptidase inhibitors for treating diabetes |
| TW200745080A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor |
| TW200745079A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| CN101360723A (zh) | 2005-09-16 | 2009-02-04 | 武田药品工业株式会社 | 制备嘧啶二酮衍生物的方法 |
| WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US8460362B2 (en) * | 2006-07-20 | 2013-06-11 | Orbusneich Medical, Inc. | Bioabsorbable polymeric medical device |
| BRPI0716971A2 (pt) * | 2006-09-13 | 2013-10-15 | Takeda Pharmaceutical | Uso de 2-6(3-amino-piperini-l-il)-3-metil-2,4-dioxo-3,4-dihidro-2 h-pirimidin-1ilmetil-4-fluoro-benxonitrila |
| US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
| TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
| CN104910128A (zh) * | 2015-06-02 | 2015-09-16 | 安徽兴东化工有限公司 | 一种2,2-二甲基四氢噻唑的制备方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2961377A (en) | 1957-08-05 | 1960-11-22 | Us Vitamin Pharm Corp | Oral anti-diabetic compositions and methods |
| US3594377A (en) * | 1967-11-07 | 1971-07-20 | Uniroyal Inc | Condensation products of n - (3 -thiazolidinylmethyl) - nitrogen base compounds |
| DE2009743A1 (de) | 1970-03-03 | 1971-09-16 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Substituierte Biguanide mit antihyperglykämischer Wirkung |
| US3960949A (en) | 1971-04-02 | 1976-06-01 | Schering Aktiengesellschaft | 1,2-Biguanides |
| CH590857A5 (en) * | 1973-05-30 | 1977-08-31 | Givaudan & Cie Sa | Substd. thiazolidine odourants flavourants - having a wide aroma spectrum and usable in small concns. |
| CH602612A5 (zh) | 1974-10-11 | 1978-07-31 | Hoffmann La Roche | |
| ATE15668T1 (de) * | 1980-12-12 | 1985-10-15 | Fine Organics Ltd | Verfahren zur herstellung von thiazolidinderivaten. |
| US4935493A (en) | 1987-10-06 | 1990-06-19 | E. I. Du Pont De Nemours And Company | Protease inhibitors |
| JPH01272570A (ja) * | 1988-04-26 | 1989-10-31 | Nippon Shokubai Kagaku Kogyo Co Ltd | 4−メチル−5−[(2−アミノエチル)−チオメチル]−イミダゾールの製法 |
| US5433955A (en) | 1989-01-23 | 1995-07-18 | Akzo N.V. | Site specific in vivo activation of therapeutic drugs |
| JPH04334357A (ja) | 1991-05-02 | 1992-11-20 | Fujirebio Inc | 酵素阻害作用を有するアシル誘導体 |
| ES2153831T3 (es) | 1991-10-22 | 2001-03-16 | New England Medical Center Inc | Inhibidores de dipeptidil-aminopeptidasa de tipo iv. |
| NO302471B1 (no) * | 1991-12-26 | 1998-03-09 | Sankyo Co | Tiazolidinforbindelser og farmasöytisk preparat |
| IL106998A0 (en) | 1992-09-17 | 1993-12-28 | Univ Florida | Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| FR2696740B1 (fr) | 1992-10-13 | 1994-12-30 | Dospharma Sa | Dérivés prodrogués de la diméthylbiguanide et applications comme médicaments. |
| WO1995011689A1 (en) | 1993-10-29 | 1995-05-04 | Trustees Of Tufts College | Use of inhibitors of dipeptidyl-aminopeptidase to block entry of hiv into cells |
| IL111785A0 (en) | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
| US5543396A (en) | 1994-04-28 | 1996-08-06 | Georgia Tech Research Corp. | Proline phosphonate derivatives |
| DE4427569A1 (de) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Verfahren zur Herstellung von Cyanimino-1,3-thiazolidin |
| US5512549A (en) | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| US5614379A (en) | 1995-04-26 | 1997-03-25 | Eli Lilly And Company | Process for preparing anti-obesity protein |
| DE122010000020I1 (de) | 1996-04-25 | 2010-07-08 | Prosidion Ltd | Verfahren zur Senkung des Blutglukosespiegels in Säugern |
| AU3224997A (en) | 1996-05-29 | 1998-01-05 | Prototek, Inc | Prodrugs of thalidomide and methods for using same as modulators of t-cell function |
| US6006753A (en) | 1996-08-30 | 1999-12-28 | Eli Lilly And Company | Use of GLP-1 or analogs to abolish catabolic changes after surgery |
| AR016751A1 (es) | 1996-11-22 | 2001-08-01 | Athena Neurosciences Inc | Metodo para inhibir la liberacion del peptido beta-amiloide en una celula, composicion farmaceutica y compuestos utiles en dicho metodo |
| WO2000001849A1 (en) | 1998-07-02 | 2000-01-13 | Invitro Diagnostics, Inc. | Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule |
| AU3960400A (en) | 1999-03-05 | 2000-09-28 | Molteni L. E C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. | Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv |
| WO2001062266A2 (en) | 2000-02-25 | 2001-08-30 | Novo Nordisk A/S | Use of dpp-iv inhibitors for the treatment of diabetes |
-
1999
- 1999-06-10 DE DE19926233A patent/DE19926233C1/de not_active Expired - Lifetime
-
2000
- 2000-04-11 CA CA002373834A patent/CA2373834C/en not_active Expired - Fee Related
- 2000-04-11 DE DE50005699T patent/DE50005699D1/de not_active Expired - Lifetime
- 2000-04-11 MX MXPA01012237A patent/MXPA01012237A/es unknown
- 2000-04-11 EP EP00925194A patent/EP1185520B1/de not_active Expired - Lifetime
- 2000-04-11 RU RU2002100203/04A patent/RU2218336C2/ru not_active IP Right Cessation
- 2000-04-11 PT PT00925194T patent/PT1185520E/pt unknown
- 2000-04-11 JP JP2001503844A patent/JP3803292B2/ja not_active Expired - Fee Related
- 2000-04-11 NZ NZ515561A patent/NZ515561A/xx not_active IP Right Cessation
- 2000-04-11 CN CNB008087253A patent/CN1169799C/zh not_active Expired - Fee Related
- 2000-04-11 ES ES00925194T patent/ES2215045T3/es not_active Expired - Lifetime
- 2000-04-11 HK HK02103306.1A patent/HK1042483B/zh not_active IP Right Cessation
- 2000-04-11 WO PCT/EP2000/003213 patent/WO2000076986A1/de not_active Ceased
- 2000-04-11 KR KR10-2001-7015763A patent/KR100467898B1/ko not_active Expired - Fee Related
- 2000-04-11 DK DK00925194T patent/DK1185520T3/da active
- 2000-04-11 AU AU43996/00A patent/AU758605B2/en not_active Ceased
- 2000-04-11 BR BR0011445-6A patent/BR0011445A/pt not_active IP Right Cessation
- 2000-04-11 AT AT00925194T patent/ATE261946T1/de active
-
2001
- 2001-12-10 US US10/012,786 patent/US6559314B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE50005699D1 (de) | 2004-04-22 |
| DE19926233C1 (de) | 2000-10-19 |
| KR100467898B1 (ko) | 2005-02-21 |
| CN1169799C (zh) | 2004-10-06 |
| HK1042483A1 (zh) | 2002-08-16 |
| CA2373834A1 (en) | 2000-12-21 |
| BR0011445A (pt) | 2002-03-19 |
| RU2218336C2 (ru) | 2003-12-10 |
| PT1185520E (pt) | 2004-08-31 |
| AU758605B2 (en) | 2003-03-27 |
| CN1355795A (zh) | 2002-06-26 |
| ES2215045T3 (es) | 2004-10-01 |
| ATE261946T1 (de) | 2004-04-15 |
| JP3803292B2 (ja) | 2006-08-02 |
| EP1185520A1 (de) | 2002-03-13 |
| KR20020022688A (ko) | 2002-03-27 |
| DK1185520T3 (da) | 2004-06-28 |
| JP2003502319A (ja) | 2003-01-21 |
| US20020082427A1 (en) | 2002-06-27 |
| EP1185520B1 (de) | 2004-03-17 |
| US6559314B2 (en) | 2003-05-06 |
| AU4399600A (en) | 2001-01-02 |
| WO2000076986A1 (de) | 2000-12-21 |
| NZ515561A (en) | 2003-06-30 |
| CA2373834C (en) | 2005-11-08 |
| MXPA01012237A (es) | 2002-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1042483B (zh) | 四氫噻唑的製造方法 | |
| MC1199A1 (fr) | Composes tricycliques | |
| IL29569A (en) | 1,4-dihydropyridine derivatives and their production | |
| SK282736B6 (sk) | Spôsob prípravy amlodipín benzénsulfonátu | |
| US4127671A (en) | P-acetamidophenyl diethylaminoacetate | |
| JPS60126284A (ja) | ピリドンカルボン酸誘導体およびその塩 | |
| JPH0587064B2 (zh) | ||
| FI63568C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara i 7-staellning substituerade 8-aminometylisoflavonderivat | |
| JPH0215067A (ja) | イソキノリンスルホンアミド誘導体 | |
| US4609659A (en) | 2,6-disubstituted derivatives of 3-nitropyrazines useful as adjuncts to radiation therapy | |
| JPH0573754B2 (zh) | ||
| US4317914A (en) | Oxazolines | |
| HU198473B (en) | Process for producing 8-thiotetrahydro-quinoline derivatives and salts thereof, as well as pharmaceutical compositions comprising same as active ingredient | |
| JPS6310955B2 (zh) | ||
| PL144481B1 (en) | Process for preparing derivatives of pyrimidinotrione | |
| US3998820A (en) | 10'-[ω-N-/1,4-diazabicyclo(4,m,o)-alkanyl/-acyl]-phenothiazines, their acidic addition salts and quaternary salts, process for producing same and use | |
| US3714166A (en) | Cocarboxylase arginate and process for the production thereof | |
| DK142172B (da) | Analogifremgangsmaade til fremstilling af basisk substituerede2-alkylamino-4-phenylimidazoliner eller syreadditionssalte heraf | |
| JPS59141565A (ja) | 向精神性活性を有するピリダジン誘導体,その製造方法および該誘導体を含有する薬剤 | |
| US4083976A (en) | 10'-( ω-N)-1,4-Diazabicyclo(4,3,0)-alkanyl-lacyl) -phenothiazine compositions | |
| JPH0324077A (ja) | イミダゾール誘導体の製法 | |
| KR850000431B1 (ko) | 피롤 유도체의 제조방법 | |
| JPS63165368A (ja) | 新規複素環化合物およびその製造法 | |
| JPH01216980A (ja) | アルキル―ピペラジニル―5,6―アルキレンピリミジン類 | |
| KR840001286B1 (ko) | 2-이미다졸린 유도체류의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| CHRG | Changes in the register |
Free format text: FROM PROBIODRUG AG TO PROSIDION LIMITED; JOURNAL NO.: 106; PUBLICATION DATE: 15-04-2005; SECTION NAME: CHANGES IN THE REGISTER 266/280 |
|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20130411 |